HALLGREN Agneta,HALLGREN Agneta,SWENSON Ralf Magnus Werner,SWENSON Ralf Magnus Werner
申请号：
SI201031791
公开号：
SI2498759T1
申请日:
2010.11.12
申请国别(地区):
SI
年份:
2018
代理人:
摘要：
The present invention provides an immediate release pharmaceutical formulation which includes a tablet or capsule formulation comprising metformin and the sodium dependent glucose transporter (SGLT2) inhibitor dapagliflozin or its propylene glycol hydrate. The present invention also provides methods of preparing the formulations and methods of treating diseases or disorders associated with SGLT2 activity employing these formulations.
